“…These patients also had increased abundance of Eggerthella , which is considered a biomarker of fragility[ 29 , 30 ]. These findings are consistent with recent studies of the gut microbiome in cirrhosis patients with sarcopenia[ 4 , 5 ]. However, body cell mass deficiency in cirrhosis patients was found to be associated with a decrease in the abundance of Coprococcus , Intestinimonas , Catenibacterium , and Barnesiellaceae in our study, which was not reported in these earlier studies[ 4 , 5 ].…”
Section: Discussionsupporting
confidence: 93%
“…These findings are consistent with recent studies of the gut microbiome in cirrhosis patients with sarcopenia[ 4 , 5 ]. However, body cell mass deficiency in cirrhosis patients was found to be associated with a decrease in the abundance of Coprococcus , Intestinimonas , Catenibacterium , and Barnesiellaceae in our study, which was not reported in these earlier studies[ 4 , 5 ]. A decrease in the abundance of the butyrate-producing Coprococcus has been reported in hemodialysis patients with sarcopenia[ 31 ].…”
Section: Discussionsupporting
confidence: 93%
“…Catenibacterium is associated with the development of insulin resistance in morbid obesity[ 35 ]; thus, it is quite possible that a decrease in its content in the gut microbiome is associated with malnutrition. Decreased abundance of Barnesiellaceae and increased abundance of Veillonella in the gut microbiome, found in our study in patients with body cell mass deficiency, have previously been described in the general cohort of sarcopenic patients[ 36 ], but not in earlier investigations of sarcopenia in cirrhosis patients[ 4 , 5 ].…”
Section: Discussionsupporting
confidence: 60%
“…Although recent publications have reported the associations of some taxa of the gut microbiome with sarcopenia diagnosed by computed tomography[ 4 , 5 ], no studies have investigated the relations between the gut microbiome and all three main body components (fat, cells, and extracellular fluid) in cirrhosis.…”
BACKGROUND
Gut dysbiosis and changes in body composition (
i.e.
, a decrease in the proportion of muscle mass and an increase in extracellular fluid) are common in cirrhosis.
AIM
To study the relationship between the gut microbiota and body composition in cirrhosis.
METHODS
This observational study included 46 patients with cirrhosis. Stool microbiome was assessed using 16S rRNA gene sequencing. Multifrequency bioelectrical impedance analysis was performed to assess body composition in these patients.
RESULTS
An increase in fat mass and a decrease in body cell mass were noted in 23/46 (50.0%) and 15/46 (32.6%) patients, respectively. Changes in the gut microbiome were not independently associated with the fat mass percentage in cirrhosis. The abundance of
Bacteroidaceae
(
P
= 0.041) and
Eggerthella
(
P
= 0.001) increased, whereas that of
Erysipelatoclostridiaceae
(
P
= 0.006),
Catenibacterium
(
P
= 0.021),
Coprococcus
(
P
= 0.033),
Desulfovibrio
(
P
= 0.043),
Intestinimonas
(
P
= 0.028), and
Senegalimassilia
(
P
= 0.015) decreased in the gut microbiome of patients with body cell mass deficiency. The amount of extracellular fluid increased in 22/46 (47.6%) patients. Proteobacteria abundance (
P
< 0.001) increased, whereas Firmicutes (
P
= 0.023), Actinobacteria (
P
= 0.026), Bacilli (
P
= 0.008),
Anaerovoraceceae
(
P
= 0.027),
Christensenellaceae
(
P
= 0.038),
Eggerthellaceae
(
P
= 0.047),
Erysipelatoclostridiaceae
(
P
= 0.015),
Erysipelotrichaceae
(
P
= 0.003),
Oscillospiraceae
(
P
= 0.024),
Rikenellaceae
(
P
= 0.002),
Collinsella
(
P
= 0.030),
Hungatella
(
P
= 0.040),
Peptococcaceae
(
P
= 0.023),
Slackia
(
P
= 0.008), and
Senegalimassilia
(
P
= 0.024) abundance decreased in these patients. Patients with clinically sig...
“…These patients also had increased abundance of Eggerthella , which is considered a biomarker of fragility[ 29 , 30 ]. These findings are consistent with recent studies of the gut microbiome in cirrhosis patients with sarcopenia[ 4 , 5 ]. However, body cell mass deficiency in cirrhosis patients was found to be associated with a decrease in the abundance of Coprococcus , Intestinimonas , Catenibacterium , and Barnesiellaceae in our study, which was not reported in these earlier studies[ 4 , 5 ].…”
Section: Discussionsupporting
confidence: 93%
“…These findings are consistent with recent studies of the gut microbiome in cirrhosis patients with sarcopenia[ 4 , 5 ]. However, body cell mass deficiency in cirrhosis patients was found to be associated with a decrease in the abundance of Coprococcus , Intestinimonas , Catenibacterium , and Barnesiellaceae in our study, which was not reported in these earlier studies[ 4 , 5 ]. A decrease in the abundance of the butyrate-producing Coprococcus has been reported in hemodialysis patients with sarcopenia[ 31 ].…”
Section: Discussionsupporting
confidence: 93%
“…Catenibacterium is associated with the development of insulin resistance in morbid obesity[ 35 ]; thus, it is quite possible that a decrease in its content in the gut microbiome is associated with malnutrition. Decreased abundance of Barnesiellaceae and increased abundance of Veillonella in the gut microbiome, found in our study in patients with body cell mass deficiency, have previously been described in the general cohort of sarcopenic patients[ 36 ], but not in earlier investigations of sarcopenia in cirrhosis patients[ 4 , 5 ].…”
Section: Discussionsupporting
confidence: 60%
“…Although recent publications have reported the associations of some taxa of the gut microbiome with sarcopenia diagnosed by computed tomography[ 4 , 5 ], no studies have investigated the relations between the gut microbiome and all three main body components (fat, cells, and extracellular fluid) in cirrhosis.…”
BACKGROUND
Gut dysbiosis and changes in body composition (
i.e.
, a decrease in the proportion of muscle mass and an increase in extracellular fluid) are common in cirrhosis.
AIM
To study the relationship between the gut microbiota and body composition in cirrhosis.
METHODS
This observational study included 46 patients with cirrhosis. Stool microbiome was assessed using 16S rRNA gene sequencing. Multifrequency bioelectrical impedance analysis was performed to assess body composition in these patients.
RESULTS
An increase in fat mass and a decrease in body cell mass were noted in 23/46 (50.0%) and 15/46 (32.6%) patients, respectively. Changes in the gut microbiome were not independently associated with the fat mass percentage in cirrhosis. The abundance of
Bacteroidaceae
(
P
= 0.041) and
Eggerthella
(
P
= 0.001) increased, whereas that of
Erysipelatoclostridiaceae
(
P
= 0.006),
Catenibacterium
(
P
= 0.021),
Coprococcus
(
P
= 0.033),
Desulfovibrio
(
P
= 0.043),
Intestinimonas
(
P
= 0.028), and
Senegalimassilia
(
P
= 0.015) decreased in the gut microbiome of patients with body cell mass deficiency. The amount of extracellular fluid increased in 22/46 (47.6%) patients. Proteobacteria abundance (
P
< 0.001) increased, whereas Firmicutes (
P
= 0.023), Actinobacteria (
P
= 0.026), Bacilli (
P
= 0.008),
Anaerovoraceceae
(
P
= 0.027),
Christensenellaceae
(
P
= 0.038),
Eggerthellaceae
(
P
= 0.047),
Erysipelatoclostridiaceae
(
P
= 0.015),
Erysipelotrichaceae
(
P
= 0.003),
Oscillospiraceae
(
P
= 0.024),
Rikenellaceae
(
P
= 0.002),
Collinsella
(
P
= 0.030),
Hungatella
(
P
= 0.040),
Peptococcaceae
(
P
= 0.023),
Slackia
(
P
= 0.008), and
Senegalimassilia
(
P
= 0.024) abundance decreased in these patients. Patients with clinically sig...
“… [3] , [4] , [5] , [6] However, most studies focused only on muscle mass but ignored muscle strength and performance, which are determinant factors of sarcopenia. [4] , [5] , [6] , [7] Given that sarcopenia has important impacts on cirrhotic outcomes, identification of risk factors that could be therapeutically modulated may have significant clinical significance in cirrhosis.…”
ObjectiveThis study was designed to analyze the structural characteristics of the intestinal flora of elderly Uygur patients with sarcopenia, thereby providing new ideas for clinical treatment.MethodsFirstly, fecal samples were collected from 40 elderly Uygur patients with sarcopenia (Sarcopenia group) and 40 healthy people (Control group). Next, significant differences in the intestinal flora between the two groups were analyzed based on 16S rDNA high‐throughput sequencing. The linear discriminant analysis effect size (LEfSe) was used to estimate the magnitude of the effect of each component (species) abundance on the differential effect. Additionally, an analysis was also performed on the relationship between the intestinal flora and the cytokines in the peripheral blood of patients with sarcopenia.ResultsThe results of β diversity showed that there were differences in the structure of the intestinal flora between the two groups. Besides, the phylum level of intestinal flora between the two groups was not significantly different. However, the difference was significant in the intestinal flora at the order, family, and genus levels between the two groups. Among them, Lachnoclostridium, Photobacterium, Anaerobic Bacillus, Hydrogenophilus, and Eubacterium were enriched in the Sarcopenia group; Prevotella 9, Firmicutes FCS020 group, Streptobacillus, Aggregatibacter, Corynebacterium, Clostridium Difficile, and Haloanaerobium were enriched in the Control group. The LEfSe outcomes further showed that Lachnoclostridium was highly enriched in the Sarcopenia group; Prevotella 9 and Firmicutes FCS020 group were significantly enriched in the Control group. Furthermore, the relative abundance of Lachnoclostridium and Streptobacillus were significantly different in patients with high and low IL‐6 levels.ConclusionIn conclusion, Lachnoclostridium is significantly enriched in the intestines of elderly Uygur patients with sarcopenia; the increase in Lachnoclostridium abundance and the decrease in Streptobacillus abundance are associated with high levels of IL‐6. Therefore, abnormal intestinal flora is related to inflammatory reflexes in patients with sarcopenia.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.